This trend is seen in patient tumours, where TUBB3 only makes up a low to moderate proportion of the TUBB mRNA pool in ovarian, breast and lung cancer (with proportions ranging up to 7.5, 18, and 16% respectively) (Leandro-García et al., 2010). Here, TUBB3 is linked to neoplasm.